Wendy Hu

High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic Indices

Sandra J. Horning, Nelson J. Chao, Robert S. Negrin et al. · Blood · 1997 · 321 citations · Full text

Medicine, Hematology, Oncology +16

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality

Ashwin Kashyap, John R. Wingard, Pablo J. Cagnoni et al. · Biology of Blood and Marrow Transplantation · 2002 · 225 citations · Full text

Pharmacy, Hematology, Pharmacology +17

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: A phase II study

Börje S. Andersson, Ashwin Kashyap, Victor G. Gian et al. · Biology of Blood and Marrow Transplantation · 2002 · 187 citations · Full text

Medicine, Hematology, Pharmacokinetics +17

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers

Rainer Storb, Karl G. Blume, Margaret O’Donnell et al. · Biology of Blood and Marrow Transplantation · 2001 · 165 citations · Full text

Medicine, Hematology, Immunology +17

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer

Robert S. Negrin, K Atkinson, Tom Leemhuis et al. · Biology of Blood and Marrow Transplantation · 2000 · 165 citations · Full text

Medicine, Hematology, Oncology +17